COVID-19 research

Scientists from Cedars-Sinai report a biologic substance created with skin cells called dermal fibroblasts could occasion a new therapy for COVID-19 patients, as it stopped SARS-CoV-2 from reproducing and protected cells when tested in human lung cells.